EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 3.0

Real-World Effectiveness of Tezepelumab in Severe Asthma: A 12-Month Canadian Cohort Study

Mathieu D Saint-Pierre iD, Samih Agaybi, Catherine B Charron, Jean-Grégoire Leduc

Journal of Asthma and Allergy · 2026-10 · Volume 19 · 1-10

DOI: 10.2147/jaa.s652986 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Asthma and Allergy, 2026-10. Verfasst von Mathieu D Saint-Pierre und 3 weiteren Autor:innen. Beteiligte Einrichtung: Respirology, Montfort Hospital, University of Ottawa, Ottawa, ON, Canada. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

asthmadyspneaexacerbationslung functionreal-world evidencetezepelumab

Autor:innen und Institutionen

  • Respirology, Montfort Hospital, University of Ottawa, Ottawa, ON, Canada.
  • Respirology, Orleans Cardiopulmonary Group, Ottawa, ON, Canada.

ORCID-Profile: Mathieu D Saint-Pierre

Zitieren

APA

Saint-Pierre, M. D., Agaybi, S., Charron, C. B., & Leduc, J. G. (2026). Real-World Effectiveness of Tezepelumab in Severe Asthma: A 12-Month Canadian Cohort Study. Journal of Asthma and Allergy, Volume 19, 1-10. https://doi.org/10.2147/jaa.s652986

Vancouver

Saint-Pierre MD, Agaybi S, Charron CB, Leduc JG. Real-World Effectiveness of Tezepelumab in Severe Asthma: A 12-Month Canadian Cohort Study. Journal of Asthma and Allergy. 2026;Volume 19:1-10. doi:10.2147/jaa.s652986

BibTeX
@article{SaintPierre2026,
  author = {Saint-Pierre, Mathieu D and Agaybi, Samih and Charron, Catherine B and Leduc, Jean-Grégoire},
  title = {Real-World Effectiveness of Tezepelumab in Severe Asthma: A 12-Month Canadian Cohort Study},
  journal = {Journal of Asthma and Allergy},
  year = {2026},
  volume = {Volume 19},
  pages = {1--10},
  doi = {10.2147/jaa.s652986}
}
Kostenlos starten →